| Trial ID: | L4388 |
| Source ID: | NCT01508949
|
| Associated Drug: |
Liraglutide
|
| Title: |
Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide|DRUG: placebo
|
| Outcome Measures: |
Primary: Change in weight | Secondary: Total fat mass (assessed by use of DEXA (dual energy X-ray absorptiometry) scan)|Waist circumference|Spontaneous energy intake assessed in connection to the ad libitum lunch meal|Appetite assessed in connection with the fixed breakfast meal (assessed by the use of VAS (visual analogue scale))|Gastric emptying rate|Energy expenditure|HbA1c (Glycosylated Haemoglobin)|Adverse events
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
35
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2001-06
|
| Completion Date: |
2002-03
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-02
|
| Locations: |
Novo Nordisk Investigational Site, Frederiksberg C, 1958, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01508949
|
